Correlation Between Neurobo Pharmaceuticals and Hillstream Biopharma
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Hillstream Biopharma, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Hillstream Biopharma.
Diversification Opportunities for Neurobo Pharmaceuticals and Hillstream Biopharma
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neurobo and Hillstream is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Hillstream Biopharma go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Hillstream Biopharma
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 1.27 times more return on investment than Hillstream Biopharma. However, Neurobo Pharmaceuticals is 1.27 times more volatile than Hillstream Biopharma. It trades about 0.0 of its potential returns per unit of risk. Hillstream Biopharma is currently generating about -0.01 per unit of risk. If you would invest 466.00 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (229.00) from holding Neurobo Pharmaceuticals or give up 49.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 13.74% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Hillstream Biopharma
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neurobo Pharmaceuticals and Hillstream Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Hillstream Biopharma
The main advantage of trading using opposite Neurobo Pharmaceuticals and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.| Neurobo Pharmaceuticals vs. Eliem Therapeutics | Neurobo Pharmaceuticals vs. HCW Biologics | Neurobo Pharmaceuticals vs. Scpharmaceuticals | Neurobo Pharmaceuticals vs. Milestone Pharmaceuticals |
| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |